S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+0.00%)
DOW   0.72 (+0.00%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:BFRABIOFRONTERA AG/ADR News Headlines

$30.50
+10.18 (+50.10 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.23
Now: $30.50
$41.96
50-Day Range
$5.60
MA: $7.60
$26.80
52-Week Range
$5.27
Now: $30.50
$55.00
Volume2.19 million shs
Average Volume81,590 shs
Market Capitalization$683.96 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69

Headlines

BIOFRONTERA AG/ADR (NASDAQ BFRA) News Headlines

Source:
DateHeadline
Result of the subscription of the 1.00 % qualified subordinated mandatory convertible bond 2020/2021Result of the subscription of the 1.00 % qualified subordinated mandatory convertible bond 2020/2021
finance.yahoo.com - August 13 at 7:16 PM
BIOFRONTERA AG/ADR (NASDAQ:BFRA) Short Interest Down 54.5% in FebruaryBIOFRONTERA AG/ADR (NASDAQ:BFRA) Short Interest Down 54.5% in February
americanbankingnews.com - August 13 at 4:26 AM
BIOFRONTERA AG/ADR (NASDAQ:BFRA) Short Interest UpdateBIOFRONTERA AG/ADR (NASDAQ:BFRA) Short Interest Update
americanbankingnews.com - August 12 at 6:12 PM
BIOFRONTERA AG/ADR (NASDAQ:BFRA) Shares Up 9.1%BIOFRONTERA AG/ADR (NASDAQ:BFRA) Shares Up 9.1%
americanbankingnews.com - August 12 at 2:07 PM
Mid-Morning Market Update: Markets Open Higher; Brinker Reports Mixed Q4 ResultsMid-Morning Market Update: Markets Open Higher; Brinker Reports Mixed Q4 Results
benzinga.com - August 12 at 1:08 PM
Biofrontera AG announces subscription price for 1.00 % qualified subordinated mandatory convertible bond 2020/2021Biofrontera AG announces subscription price for 1.00 % qualified subordinated mandatory convertible bond 2020/2021
finance.yahoo.com - August 10 at 11:15 AM
BIOFRONTERA AG/ADR (NASDAQ:BFRA) Reaches New 1-Year High at $54.99BIOFRONTERA AG/ADR (NASDAQ:BFRA) Reaches New 1-Year High at $54.99
americanbankingnews.com - August 5 at 5:40 PM
Supervisory Board of Biofrontera AG renews Management Board appointmentSupervisory Board of Biofrontera AG renews Management Board appointment
finance.yahoo.com - July 23 at 12:45 PM
Biofrontera reports preliminary H1 salesBiofrontera reports preliminary H1 sales
seekingalpha.com - July 14 at 8:53 AM
Biofrontera reports preliminary unaudited sales revenue for the first six months of 2020Biofrontera reports preliminary unaudited sales revenue for the first six months of 2020
finance.yahoo.com - July 14 at 8:53 AM
Biofrontera confirms financing needBiofrontera confirms financing need
finance.yahoo.com - June 30 at 8:58 AM
Results of the 2020 Annual General Meeting of Biofrontera AGResults of the 2020 Annual General Meeting of Biofrontera AG
finance.yahoo.com - May 28 at 4:53 PM
Biofrontera AG (BFRA) CEO Hermann Lübbert on Q1 2020 Results - Earnings Call TranscriptBiofrontera AG (BFRA) CEO Hermann Lübbert on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 20 at 3:27 PM
Biofrontera AG (BFRA) Q1 2020 Earnings Call TranscriptBiofrontera AG (BFRA) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 20 at 3:27 PM
Biofrontera reports Q1 2020 financial resultsBiofrontera reports Q1 2020 financial results
finance.yahoo.com - May 19 at 2:37 PM
Biofrontera dismisses case against DUSA Pharmaceuticals, Inc. in California state courtBiofrontera dismisses case against DUSA Pharmaceuticals, Inc. in California state court
finance.yahoo.com - May 13 at 8:52 AM
Biofrontera announces conference call to be held on May 20, 2020 to discuss first quarter 2020 financial resultsBiofrontera announces conference call to be held on May 20, 2020 to discuss first quarter 2020 financial results
finance.yahoo.com - May 12 at 5:51 PM
Biofronteras New Deal, And Other News: The Good, Bad And Ugly Of BiopharmaBiofrontera's New Deal, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - April 22 at 4:02 AM
Biofrontera AG (BFRA) CEO Hermann Lübbert on Q4 2019 Results - Earnings Call TranscriptBiofrontera AG (BFRA) CEO Hermann Lübbert on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - April 21 at 6:01 PM
Biofrontera AG (BFRA) Q4 2019 Earnings Call TranscriptBiofrontera AG (BFRA) Q4 2019 Earnings Call Transcript
www.fool.com - April 21 at 6:01 PM
Biofrontera Reports Full Year 2019 Financial ResultsBiofrontera Reports Full Year 2019 Financial Results
finance.yahoo.com - April 20 at 3:14 PM
Biofrontera inks deal for Ameluz with MaruhoBiofrontera inks deal for Ameluz with Maruho
seekingalpha.com - April 20 at 8:24 AM
Biofrontera AG enters into exclusive license agreement with Maruho Co., Ltd.Biofrontera AG enters into exclusive license agreement with Maruho Co., Ltd.
finance.yahoo.com - April 20 at 8:24 AM
Biofrontera reports preliminary unaudited sales revenue for the first three months of 2020Biofrontera reports preliminary unaudited sales revenue for the first three months of 2020
finance.yahoo.com - April 17 at 8:01 AM
Biofrontera AG to propose resolution for ordinary capital increase to the Annual General MeetingBiofrontera AG to propose resolution for ordinary capital increase to the Annual General Meeting
finance.yahoo.com - April 16 at 2:52 PM
Biofrontera announces conference call to be held...Biofrontera announces conference call to be held...
www.benzinga.com - April 9 at 2:28 PM
Biofrontera announces conference call to be held on April 21, 2020 to discuss full year 2019 financial resultsBiofrontera announces conference call to be held on April 21, 2020 to discuss full year 2019 financial results
finance.yahoo.com - April 9 at 2:28 PM
Biofrontera AG withdraws subscription offers for mandatory convertible bondsBiofrontera AG withdraws subscription offers for mandatory convertible bonds
finance.yahoo.com - March 23 at 2:12 PM
MNK Mar 2020 8.000 callMNK Mar 2020 8.000 call
finance.yahoo.com - March 21 at 4:30 AM
MRK Mar 2020 70.000 putMRK Mar 2020 70.000 put
finance.yahoo.com - March 21 at 4:30 AM
Biofrontera implements comprehensive measures to reduce costs during COVID-19 pandemicBiofrontera implements comprehensive measures to reduce costs during COVID-19 pandemic
finance.yahoo.com - March 20 at 7:20 AM
Biofrontera AG signs non-binding term sheet for licensing agreement for Ameluz® in Poland with medac GmbH Sp. z o.o.Biofrontera AG signs non-binding term sheet for licensing agreement for Ameluz® in Poland with medac GmbH Sp. z o.o.
finance.yahoo.com - March 13 at 12:17 PM
Biofrontera AG extends subscription period for mandatory convertible bondsBiofrontera AG extends subscription period for mandatory convertible bonds
finance.yahoo.com - March 12 at 3:25 PM
European Commission approves use of Ameluz® for the treatment of actinic keratosis on extremities and trunk/neckEuropean Commission approves use of Ameluz® for the treatment of actinic keratosis on extremities and trunk/neck
finance.yahoo.com - March 10 at 12:58 PM
Biofrontera entered into binding term sheet with Maruho Co., Ltd.Biofrontera entered into binding term sheet with Maruho Co., Ltd.
finance.yahoo.com - March 3 at 8:41 AM
Biofrontera AG resolves to issue qualified subordinated mandatory convertible bondsBiofrontera AG resolves to issue qualified subordinated mandatory convertible bonds
finance.yahoo.com - February 26 at 1:27 PM
Biofrontera provides clinical development updatesBiofrontera provides clinical development updates
finance.yahoo.com - February 19 at 7:36 AM
European Medicines Agency recommends indication expansion of Ameluz® for treatment of actinic keratoses on the extremities and trunk/neckEuropean Medicines Agency recommends indication expansion of Ameluz® for treatment of actinic keratoses on the extremities and trunk/neck
finance.yahoo.com - February 3 at 8:56 AM
Organizational restructuring of Biofrontera and resignation of Chief Commercial Officer Christoph DünwaldOrganizational restructuring of Biofrontera and resignation of Chief Commercial Officer Christoph Dünwald
finance.yahoo.com - January 31 at 1:30 PM
European advisory group backs expanded label for Biofronteras AmeluzEuropean advisory group backs expanded label for Biofrontera's Ameluz
seekingalpha.com - January 31 at 8:29 AM
Biofrontera announces 1-year follow-up results for its phase III study of photodynamic therapy for actinic keratosis on the extremities and trunk/neckBiofrontera announces 1-year follow-up results for its phase III study of photodynamic therapy for actinic keratosis on the extremities and trunk/neck
finance.yahoo.com - January 14 at 1:43 AM
Biofrontera reports preliminary Q4 and FY 2019 salesBiofrontera reports preliminary Q4 and FY 2019 sales
seekingalpha.com - January 10 at 5:19 PM
Biofrontera announces preliminary sales figures for the full year 2019, record sales in the 4th quarterBiofrontera announces preliminary sales figures for the full year 2019, record sales in the 4th quarter
finance.yahoo.com - January 10 at 5:19 PM
BRIEF-Biofrontera Reorganizes Its U.S. BusinessBRIEF-Biofrontera Reorganizes Its U.S. Business
www.msn.com - January 6 at 4:29 PM
Biofrontera strengthens commercial focus with reorganization of its US businessBiofrontera strengthens commercial focus with reorganization of its US business
finance.yahoo.com - January 6 at 4:29 PM
Extraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majorityExtraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majority
finance.yahoo.com - December 20 at 12:16 PM
Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera Inc.Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera Inc.
finance.yahoo.com - December 13 at 9:31 AM
Biofrontera (BFRA) Presents At German Equity Forum 2019 - SlideshowBiofrontera (BFRA) Presents At German Equity Forum 2019 - Slideshow
seekingalpha.com - December 5 at 7:07 PM
Biofrontera to Participate in Upcoming Investor ConferencesBiofrontera to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 22 at 2:25 PM
Biofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2019 Results - Earnings Call TranscriptBiofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 20 at 12:53 AM
This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.